SCHEMBL6833702

SCHEMBL6833702

Fc1ccc2c(c1)nc(C(F)(F)F)c1nc(-c3ccccc3)n(CCN3CCNCC3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 2/20 0.39
TDO2 P48775 2/20 0.38
ALDH1A1 P00352 4/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTR6 P50406 2/20 0.36
SLC6A3 Q01959 1/20 0.36
ADRB2 P07550 1/20 0.34
KDM4E B2RXH2 3/20 0.34
CYP3A4 P08684 3/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
AVPR1B P47901 1/20 0.34
GRM2 Q14416 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839980 0.91 ADRB2 (0.39) ALDH1A1TSHRSMN1; SMN2HTR6ADRB2
SCHEMBL6838642 0.90 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2HTR6ADRB2
SCHEMBL6837641 0.90 EGFR (0.42) ALDH1A1TSHRSMN1; SMN2HTR6ADRB2
SCHEMBL6838102 0.86 SLC6A2 (0.37) SLC6A2SLC6A4KCNH2TDO2SLC6A3
SCHEMBL6833986 0.86 AVPR2 (0.35) HTR6ACP1
SCHEMBL6838640 0.86 KCNH2 (0.37) SLC6A2SLC6A4KCNH2TDO2ALDH1A1
SCHEMBL6838564 0.86 KCNH2 (0.37) SLC6A2SLC6A4KCNH2TDO2TSHR
SCHEMBL6840144 0.84 SLC6A2 (0.37) SLC6A2SLC6A4KCNH2TDO2HTR6
SCHEMBL6837688 0.83 SLC6A2 (0.36) SLC6A2SLC6A4KCNH2TDO2HTR6
SCHEMBL6837740 0.81 SLC6A2 (0.42) SLC6A2SLC6A4KCNH2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 SLC6A2 4336/4885SLC6A4 3973/4885KCNH2 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.